BioValley France and BIOPRO Baden-Württemberg organize their 18th joint Meet & Match event taking place on the 3rd of December, 2020. It will be hosted as an online event offering interesting presentations, matchmaking pitches as well as networking sessions.
BioValley France and their German network partner BIOPRO Baden-Württemberg GmbH organise their 18th joint «Meet & Match» event. Focusing on «Immuno-oncology», the virtual event takes place on Thursday, December 3, 2020.
Thematically, the focus of this networking event is on present and future trends in the field of Immuno-oncology. 10 presentations from researchers and industry will provide further insight into exciting research and development projects displaying different therapeutic and diagnostic approaches.
The Meet & Match addresses research institutions, companies and start-up's – from the French region Grand Est and Baden-Württemberg – with an interest in immunology, cancer diagnostics and drug development. The objective is to establish new contacts, encourage participants to initiate cooperation or joint developments as well as to gain a better understanding of immunological mechanisms to fight cancer. The lunch and coffee breaks offer extensive digital networking opportunities. Our event will be hosted by veertly.
During the «Short presentation session» participants may introduce their company or research group to enable intense networking opportunities. You can apply for a 2-3-minute short presentation upon registration until Friday, November 13, 2020. Please note that the number of short presentations is limited and that the session is arranged for research institutions or companies being active in R&D or production. Selection is made by the organisers.
The registration is already closed. Are you still interested in our event? Please contact firstname.lastname@example.org.
9:00 | Login & warm-up
9:30 | Introduction: Agnès Legoll, BioValley France & BIOPRO Baden-Württemberg
9:45 | Prof. Dr. Christophe Borg – CHRU Besançon Oncologie Médicale (keynote 1)«Characterization and immunomodulation of tumor infiltrating lymphocytes in gastrointestinal cancers»
10:15 | Dr. Frank Schwöbel – Immatics Biotechnologies, Tübingen (keynote 2)«Targeting of Tumor-specific HLA Ligands with Bispecific T cell Engaging Receptor (TCER™) Molecules»
10:45 | Dr. Nicolas Basse – Sanofi «A focused Platforms and Pathways approach to support Immuno-Oncology Pipeline»
11:00 | Prof. Dr. Susanne Bailer – Fraunhofer IGB, Stuttgart«TheraVision – Platform technology for the development, production and testing of oncolytic viruses»
11:15 | Coffee Break
11:30 | Dr. Jean-Marc Balloul – Transgene«Oncolytic virotherapy, a novel class of multifunctional immunotherapeutics»
11:45 | Short Presentation Session
12:30 | Networking
13:30 | Lunch Break
14:00 | Prof. Dr. Kerstin Otte – Hochschule Biberach (HBC), Biberach«Cell line development: novel concepts for optimized protein production»
14:15 | Dr. Albin Jeanne – Apmonia Therapeutics«Targeting the tumor microenvironment through innovative and personalized peptide-based strategies»
14:30 | Dr. Michael Burnet – Synovo, Tübingen«Immuno-oncology models and effects of micro-environment modulators»
14:45 | Dr. Jessica Matta – Odimma«Active Personalized Cancer Immunotherapy»
15:00 | Coffee Break
15:15 | Dr. Martin Steiner – Synimmune, Tübingen«Optimized mono- and bispecific antibodies for treatment of AML»
15:30 | Prof. Dr. Céline Mascaux – Hôpitaux Universitaires de Strasbourg, Thoracic oncology«Immune evasion as a target in lung cancer: to treat, to cure and to prevent»
15:45 | Networking
17:00 | End of event
Please note: The programm is subject to change